Platform Development for Cellular Aging
Aging-associated diseases (e.g., heart disease, dementia, frailty)
Pre-clinicalActive
Key Facts
Indication
Aging-associated diseases (e.g., heart disease, dementia, frailty)
Phase
Pre-clinical
Status
Active
Company
About BioViva Science
BioViva Science is a private, pre-clinical stage biotech firm targeting the biology of aging as a therapeutic area. The company is developing a dual-platform gene therapy approach, utilizing established AAV vectors and a proprietary CMV-based platform designed for larger genetic payloads to address complex, multi-factorial age-related diseases. While presenting an ambitious vision for treating cellular aging itself, the company appears to be in an early development and fundraising stage, with its primary public-facing asset being an open-access gene therapy database called CodeKeeper™.
View full company profile